Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.

Chronic humoral rejection of human kidney allografts is associated with MMP-2 accumulation in podocytes and its release in the urine.
复制标题

DOI:
10.1111/j.1600-6143.2010.03290.x
复制
发表时间:
2010-11
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
通讯作者:
Zorn E
Zorn E
中科院分区:
其他
文献类型:
--
作者:
Wong W;DeVito J;Nguyen H;Sarracino D;Porcheray F;Dargon I;Pelle PD;Collins AB;Tolkoff-Rubin N;Smith RN;Colvin R;Zorn E

文献摘要

参考文献

被引文献

相似文献

慢性体液性排斥反应(Chronic humoral rejection,CHR)是肾移植术后晚期移植肾衰竭的重要原因.总的来说,对子宫内膜异位症的病理生理学了解甚少。基质金属蛋白酶-2(MMP-2)是一种IV型胶原酶,在以前的研究中与慢性肾脏疾病和同种异体移植排斥反应有关。我们研究了MMP-2的存在,在同种异体移植活检和尿中的肾移植受者与CHR。MMP-2染色检测足细胞的免疫组化为所有的肾移植患者,但不常见的患者与其他肾脏并发症。尿MMP-2水平在膀胱癌患者(中位数4942 pg/mL,N = 27)中也显著高于非膀胱癌患者(中位数598 pg/mL,N = 65; p < 0.001)。尿MMP-2水平升高与高水平的蛋白尿在膀胱癌和非膀胱癌患者。纵向分析表明,尿液MMP-2的增加与活检记录的CHR的初步诊断一致。使用酶法,我们证明,MMP-2是目前在其活跃的形式在尿中的CHR患者。总体而言,我们的研究结果与MMP-2肾小球损伤以及间质纤维化和肾小管萎缩观察CHR患者。
Chronic humoral rejection (CHR) is an important cause of late graft failures following kidney transplantation. Overall, the pathophysiology of CHR is poorly understood. Matrix metalloproteinase-2 (MMP-2), a type IV collagenase, has been implicated in chronic kidney disease and allograft rejection in previous studies. We examined the presence of MMP-2 in allograft biopsies and in the urine of kidney transplant recipients with CHR. MMP-2 staining was detected by immunohistochemistry in podocytes for all CHR patients but less frequently in patients with other renal complications. Urinary MMP-2 levels were also significantly higher in CHR patients (median 4942 pg/mL, N = 27) compared to non-CHR patients (median 598 pg/mL, N = 65; p < 0.001). Elevated urinary MMP-2 correlated with higher levels of proteinuria in both CHR and non-CHR patients. Longitudinal analysis indicated that increase in urine MMP-2 coincided with initial diagnosis of CHR as documented by the biopsies. Using an enzymatic assay, we demonstrated that MMP-2 was present in its active form in the urine of patients with CHR. Overall, our findings associate MMP-2 with glomerular injury as well as interstitial fibrosis and tubular atrophy observed in patients with CHR.
DOI: 10.1093/ndt/15.12.2041
发表时间: 2000-12-01
影响因子: 6.1
作者:
Rodrigo, E;López-Hoyos, M;Arias, M
通讯作者: Arias, M
DOI: 10.1097/01.tp.0000174338.97313.5a
发表时间: 2005-11-15
期刊: TRANSPLANTATION
影响因子: 6.2
作者:
Terasaki, PI;Ozawa, M
通讯作者: Ozawa, M
DOI: 10.1038/ki.1995.150
发表时间: 1995-04-01
影响因子: 19.6
作者:
BARICOS, WH;CORTEZ, SL;SCHNAPER, HW
通讯作者: SCHNAPER, HW
DOI: 10.1111/j.1600-6143.2006.01644.x
发表时间: 2007-02-01
影响因子: 8.8
作者:
Terasaki, P. I.;Ozawa, M.;Castro, R.
通讯作者: Castro, R.
DOI: 10.1046/j.1523-1755.1999.00299.x
发表时间: 1999-02-01
影响因子: 19.6
作者:
Racusen, LC;Solez, K;Yamaguchi, Y
通讯作者: Yamaguchi, Y